Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Comparison to Placebo in Patients With Hypertension and Albuminuria

NCT02376075 is registered in ClinicalTrials.gov with ikfe-CRO GmbH as lead sponsor.

NCT NCT02376075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Comparison to Placebo in Patients With Hypertension and Albuminuria
Lead sponsor
ikfe-CRO GmbH
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
September 30, 2014
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, arterial hypertension